The number of mothers requiring and receiving a blood transfusion was higher in the oxytocin group than in the misoprostol group, but the difference did not reach statistical significance (2.9% versus 1.2%, p = 0.058).
← all excerpts
Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial.
1
0.0580
0.0580